drugset / Trial / NCT06549686
A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee
RandomizedParallel-groupSingle-blindTreatment
Summary
To evaluate the efficacy and safety of CLS2901C human allogenic chondrocyte sheets used in the osteotomy + RMSC group compared to in the osteotomy alone group of patients with osteoarthritis of the knee (OAK).
Timeline
- Start
- 2023-10-20
- Primary completion
- 2028-12-31
- Completion
- 2031-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CLS2901C | Cell therapy | — | — |